仅行撕囊的 Descemet 膜内皮角膜移植术治疗 Fuchs 内皮角膜营养不良：会成为金标准吗？
Descemet Stripping Only for Fuchs Endothelial Corneal Dystrophy: Will It Become the Gold Standard?
机构信息
Department of Ophthalmology, NYU Grossman School of Medicine, New York, NY.
出版信息
Cornea. 2022 Mar 1;41(3):269-271. doi: 10.1097/ICO.0000000000002796.
PMID:34864799
Abstract
Descemet stripping only (DSO) has become a viable treatment option for certain cases of Fuchs Endothelial Corneal Dystrophy (FECD). This article describes the history of the development of DSO, its current status, and what successful DSO tells us about the pathophysiology of FECD. Remaining questions and future directions are also highlighted.
摘要
Descemet 膜撕除术（DSO）已成为某些 Fuchs 内皮角膜营养不良（FECD）病例的可行治疗选择。本文介绍了 DSO 的发展历史、现状，以及 DSO 的成功为我们了解 FECD 的病理生理学提供了哪些启示。本文还强调了尚存的问题和未来的方向。
Zotero 插件